Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies

Abstract

Acute and chronic inflammatory neuropathies are associated with an increase in levels of NfL in CSF and plasma, but NfL is validated as a prognostic biomarker only in GBS. NfL could be used in differentiating patients with MMN from ALS. T-tau in plasma is a novel biomarker that could be used in a diagnostic assessment of patients with acute and chronic inflammatory polyneuropathies.

References

Page 1

	Year	Citations
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision Peter Van den Bergh, Robert D. M. Hadden, P. Bouché, European Journal of Neurology	2010	1.1K
CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY Richard AC Hughes, John Newsom–Davis, G D Perkin, The Lancet Pain MedicineNeuropathic PainNeurologyNeuropathologyMedicine	1978	1.1K
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy Richard AC Hughes, S. Bensa, Hugh J. Willison, Annals of Neurology Autoimmune DiseaseChronic InflammatoryCrossover TrialMedicineIntravenous Immunoglobulin	2001	617
Tau Kinetics in Neurons and the Human Central Nervous System Chihiro Sato, Nicolas R. Barthélemy, Kwasi G. Mawuenyega, Neuron NeurodynamicsNeurophysiologySynaptic TransmissionPhysiologyTau Kinetics	2018	573
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision Journal of the Peripheral Nervous System Peripheral Nerve InjuryNeurological DisorderClinical NeurologyPeripheral NervePeripheral Nerves	2010	554
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial Rinske van Koningsveld, P.I.M. Schmitz, FGA van der Meché, The Lancet Autoimmune DiseaseIntravenous ImmunoglobulinImmunologyClinical TrialsAutoimmunity	2004	365
Distribution of tau proteins in the normal human central and peripheral nervous system. John Q. Trojanowski, Theresa Schuck, Maria Luiza Gava Schmidt, Journal of Histochemistry & Cytochemistry Anti-tau MabImmunologyMolecular BiologyNeurochemical BiomarkersPeripheral Nervous System	1989	323
European Federation of Neurological Societies/Peripheral Nerve Society Guideline* on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision Journal of the Peripheral Nervous System	2010	245
Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study Jeffrey Randall, Erik Mörtberg, Gail K. Provuncher, Resuscitation Pilot StudyNeurodegenerative DiseasesHypoxic Brain InjuryTraumatic Cardiac ArrestNeurochemical Biomarkers	2012	226
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation Lorenzo Gaetani, Kina Höglund, Lucilla Parnetti, Alzheimer s Research & Therapy	2018	185

Page 1